Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inna S Afonina

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
The FEBS Journal|July 19, 2022
Infection and immunity: 'There Are Things Out There You (Don't) Need To Know About'Inna S Afonina, Eik Hoffmann
Nature Immunology|February 17, 2016
Trabid epigenetically drives expression of IL-12 and IL-23Inna S Afonina, Rudi Beyaert
The FEBS Journal|March 28, 2023
Novel role for linear ubiquitination in regulating NFAT1 stabilityFemke De Meyer, Inna S Afonina
Biochemical Pharmacology|August 29, 2021
Polo-like kinase 1 (PLK1) signaling in cancer and beyondStyliani Iliaki, Rudi Beyaert, Inna S Afonina
Frontiers in Immunology|November 7, 2022
Editorial: Post-translational modifications of extracellular signaling molecules and antigens in immune and inflammatory responsesInna S Afonina, Loredana Frasca, Gaby Palmer
Cellular and Molecular Life Sciences : CMLS|January 2, 2021
Immune responses and therapeutic options in psoriasisInna S Afonina, Elien Van Nuffel, Rudi Beyaert
The Journal of Investigative Dermatology|August 26, 2018
Psoriasis Plays a Wild CARDElien Van Nuffel, Inna S Afonina, Rudi Beyaert
The FEBS Journal|May 22, 2015
MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expressionInna S Afonina, Lynn Elton, Isabelle Carpentier, et al.
Biochemical Pharmacology|January 9, 2018
Dichotomous function of IL-33 in health and disease: From biology to clinical implicationsHarald Braun, Inna S Afonina, Christina Mueller, et al.
Nature Immunology|July 20, 2017
Limiting inflammation-the negative regulation of NF-κB and the NLRP3 inflammasomeInna S Afonina, Zhenyu Zhong, Michael Karin, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
The FEBS Journal|July 19, 2022
Infection and immunity: 'There Are Things Out There You (Don't) Need To Know About'Inna S Afonina, Eik Hoffmann
Nature Immunology|February 17, 2016
Trabid epigenetically drives expression of IL-12 and IL-23Inna S Afonina, Rudi Beyaert
The FEBS Journal|March 28, 2023
Novel role for linear ubiquitination in regulating NFAT1 stabilityFemke De Meyer, Inna S Afonina
Biochemical Pharmacology|August 29, 2021
Polo-like kinase 1 (PLK1) signaling in cancer and beyondStyliani Iliaki, Rudi Beyaert, Inna S Afonina
Frontiers in Immunology|November 7, 2022
Editorial: Post-translational modifications of extracellular signaling molecules and antigens in immune and inflammatory responsesInna S Afonina, Loredana Frasca, Gaby Palmer
Cellular and Molecular Life Sciences : CMLS|January 2, 2021
Immune responses and therapeutic options in psoriasisInna S Afonina, Elien Van Nuffel, Rudi Beyaert
The Journal of Investigative Dermatology|August 26, 2018
Psoriasis Plays a Wild CARDElien Van Nuffel, Inna S Afonina, Rudi Beyaert
The FEBS Journal|May 22, 2015
MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expressionInna S Afonina, Lynn Elton, Isabelle Carpentier, et al.
Biochemical Pharmacology|January 9, 2018
Dichotomous function of IL-33 in health and disease: From biology to clinical implicationsHarald Braun, Inna S Afonina, Christina Mueller, et al.
Nature Immunology|July 20, 2017
Limiting inflammation-the negative regulation of NF-κB and the NLRP3 inflammasomeInna S Afonina, Zhenyu Zhong, Michael Karin, et al.
Pageof 4